Ignite Creation Date:
2024-05-06 @ 2:07 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04224688
Status:
TERMINATED
Last Update Posted:
2023-08-08
First Post:
2020-01-08
Brief Title:
A Study to Assess the Efficacy Safety and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia ITP
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-08
First Submit QC Date:
January 8 2020
Study First Post Date:
2020-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-12-19
Disp First Submit QC Date:
August 4 2023
Disp First Post Date:
2023-08-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-08-04
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL